Free fatty acids, insulin resistance, and type 2 diabetes mellitus
- PMID: 10354364
- DOI: 10.1046/j.1525-1381.1999.99220.x
Free fatty acids, insulin resistance, and type 2 diabetes mellitus
Abstract
Evidence is presented that shows that free fatty acids (FFA) are one important link between obesity, insulin resistance, and type 2 diabetes. Plasma FFA levels are elevated in most obese subjects, and physiological elevations of plasma FFA inhibit insulin-stimulated glucose uptake into muscle. This peripheral insulin resistance is caused by an FFA-induced defect, which develops 3-4 hr after raising plasma FFA, in insulin-stimulated glucose transport or phosphorylation, or both. This resistance is also caused by a second defect, which develops after 4-6 hr, consisting of inhibition of glycogen synthase activity. Whether elevated plasma FFA levels inhibit insulin action on endogenous glucose production (EGP), that is, cause central insulin resistance, is more difficult to demonstrate. On the one hand, FFA increase gluconeogenesis, which enhances EGP; on the other hand, FFA increase insulin secretion, which decreases EGP. Basal plasma FFA support approximately one third of basal insulin secretion in diabetic and nondiabetic subjects and, hence, are responsible for some of the hyperinsulinemia in obese, normoglycemic patients. In addition, elevated plasma FFA levels potentiate glucose-stimulated insulin secretion acutely and during prolonged exposure (48 hr). It is hypothesized that obese subjects who are genetically predisposed to develop type 2 diabetes will become partially "lipid blind," that is, unable to compensate for their FFA-induced insulin resistance with FFA-induced insulin oversecretion. The resulting insulin resistance/secretion deficit will then have to be compensated for with glucose-induced insulin secretion, which, because of their partial "glucose blindness," will result in hyperglycemia and eventually in type 2 diabetes.
Similar articles
-
Free fatty acids (FFA), a link between obesity and insulin resistance.Front Biosci. 1998 Feb 15;3:d169-75. doi: 10.2741/a272. Front Biosci. 1998. PMID: 9450985 Review.
-
Free fatty acids-the link between obesity and insulin resistance.Endocr Pract. 2001 Jan-Feb;7(1):44-51. doi: 10.4158/EP.7.1.44. Endocr Pract. 2001. PMID: 11250769 Review.
-
Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.Diabetes. 1997 Jan;46(1):3-10. Diabetes. 1997. PMID: 8971073 Review.
-
Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.Eur J Clin Invest. 2002 Jun;32 Suppl 3:14-23. doi: 10.1046/j.1365-2362.32.s3.3.x. Eur J Clin Invest. 2002. PMID: 12028371 Review.
-
Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes.Exp Clin Endocrinol Diabetes. 2003 May;111(3):121-4. doi: 10.1055/s-2003-39781. Exp Clin Endocrinol Diabetes. 2003. PMID: 12784183 Review.
Cited by
-
Biomechanism of chlorogenic acid complex mediated plasma free fatty acid metabolism in rat liver.BMC Complement Altern Med. 2016 Aug 5;16:274. doi: 10.1186/s12906-016-1258-y. BMC Complement Altern Med. 2016. PMID: 27495925 Free PMC article.
-
Fatty acid- and cholesterol transporter protein expression along the human intestinal tract.PLoS One. 2010 Apr 29;5(4):e10380. doi: 10.1371/journal.pone.0010380. PLoS One. 2010. PMID: 20454462 Free PMC article.
-
Plasma Levels of Free Fatty Acids in Women with Gestational Diabetes and Its Intrinsic and Extrinsic Determinants: Systematic Review and Meta-Analysis.J Diabetes Res. 2019 Aug 18;2019:7098470. doi: 10.1155/2019/7098470. eCollection 2019. J Diabetes Res. 2019. PMID: 31531374 Free PMC article.
-
Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.J Biol Chem. 2016 Mar 25;291(13):6626-40. doi: 10.1074/jbc.M115.699504. Epub 2016 Jan 12. J Biol Chem. 2016. PMID: 26757816 Free PMC article.
-
PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity.Am J Physiol Endocrinol Metab. 2010 Aug;299(2):E145-61. doi: 10.1152/ajpendo.00755.2009. Epub 2010 Apr 6. Am J Physiol Endocrinol Metab. 2010. PMID: 20371735 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical